CIBC Private Wealth Group
AMPH icon

CIBC Private Wealth Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

CIBC Private Wealth Group’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$23.5K Buy
878
+157
+22% +$4.04K ﹤0.01% 2114
2025
Q3 		$19.2K Hold
721
– – ﹤0.01% 2168
2025
Q2 		$16.6K Sell
721
-76
-10% -$1.89K ﹤0.01% 2087
2025
Q1 		$18.9K Buy
797
+236
+42% +$7.54K ﹤0.01% 2012
2024
Q4 		$20.5K Sell
561
-16
-3% -$732 ﹤0.01% 2047
2024
Q3 		$28K Buy
577
+249
+76% +$10.9K ﹤0.01% 2009
2024
Q2 		$12.3K Buy
328
+29
+10% +$1.2K ﹤0.01% 2219
2024
Q1 		$13K Buy
+299
New +$15.4K ﹤0.01% 2178

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIBC Private Wealth Group's AMPH Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Amphastar Pharmaceuticals (AMPH) stake by 22% in Q4 2025, buying an estimated $4.04K and bringing the position to 878 shares worth $23.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2114.

CIBC Private Wealth Group first reported a position in AMPH in Q1 2024 and has held it in 8 quarters since. The position peaked at $28K in Q3 2024. 235 funds tracked by Wall St. Rank hold AMPH as of Q4 2025.

  • CIBC Private Wealth Group held 878 shares of Amphastar Pharmaceuticals worth $23.5K as of Q4 2025.
  • CIBC Private Wealth Group bought 157 Amphastar Pharmaceuticals shares in Q4 2025, an estimated $4.04K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2114 holding.
  • CIBC Private Wealth Group first reported a position in Amphastar Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
  • CIBC Private Wealth Group's Amphastar Pharmaceuticals position peaked at $28K in Q3 2024.
  • 235 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.